Cocrystal Pharma
(NASDAQ) COCP
Cocrystal Pharma Financials at a Glance
Market Cap
$20.82M
Revenue (TTM)
$0.00
Net Income (TTM)
$8.83M
EPS (TTM)
$-0.79
P/E Ratio
-1.91
Dividend
$0.00
Beta (Volatility)
0.66 (Low)
Dividend
$0.00
Beta (Volatility)
0.66 (Low)
Price
$1.50
Volume
4,437,370
Open
$1.70
Price
$1.50
Volume
4,437,370
Open
$1.70
Previous Close
$1.50
Daily Range
$1.37 - $1.99
52-Week Range
$0.86 - $2.67
Dividend
$0.00
Beta (Volatility)
0.66 (Low)
Price
$1.50
Volume
4,437,370
Open
$1.70
Previous Close
$1.50
Daily Range
$1.37 - $1.99
52-Week Range
$0.86 - $2.67
COCP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cocrystal Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
10
CEO
Sam Lee, PhD; James Joseph Martin, MBA, CPA
Website
www.cocrystalpharma.comHeadquarters
Bothell, WA 98011, US
COCP Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-111%
Return on Capital
-1%
Return on Assets
-91%
Earnings Yield
-52.36%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$20.82M
Shares Outstanding
13.79M
Volume
4.44M
Short Interest
0.00%
Avg. Volume
2.28M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$9.02M
EBITDA
$9.02M
Operating Cash Flow
$8.19M
Capital Expenditure
$12.00K
Free Cash Flow
$8.20M
Cash & ST Invst.
$7.03M
Total Debt
$1.50M
Cocrystal Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.39M
+5078.6%
Gross Margin
0.00%
N/A
Market Cap
$20.82M
N/A
Market Cap/Employee
$1.89M
N/A
Employees
11
N/A
Net Income
$2.43M
+25.7%
EBITDA
$2.58M
+20.3%
Quarterly Fundamentals
Net Cash
$5.52M
-31.5%
Accounts Receivable
$706.00K
-41.9%
Inventory
$0.00
N/A
Long Term Debt
$2.34M
+55.6%
Short Term Debt
$668.00K
+121.9%
Return on Assets
-90.93%
N/A
Return on Invested Capital
-1.20%
N/A
Free Cash Flow
$1.74M
+45.1%
Operating Cash Flow
$1.74M
+45.1%